Potent effect of the MDM2 inhibitor AMG232 on suppression of glioblastoma stem cells
Nam-Gu Her(Samsung Medical Center), Do‐Hyun Nam(Samsung (South Korea))
Cited by 66
Related Papers
KML001, a Telomere-Targeting Drug, Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy and Radiotherapy through DNA Damage and Apoptosis
|BioMed Research International|2014|23